107 related articles for article (PubMed ID: 31615365)
1. Access to Direct-Acting Antiviral Treatment for Hepatitis C Virus Among Veterans With Serious Mental Illness.
Travaglini LE; Kreyenbuhl J; Graydon M; Brown CH; Goldberg R; Himelhoch S; Fang LJ; Slade E
Psychiatr Serv; 2020 Feb; 71(2):192-195. PubMed ID: 31615365
[TBL] [Abstract][Full Text] [Related]
2. Decentralised hepatitis C testing and treatment in rural Cambodia: evaluation of a simplified service model integrated in an existing public health system.
Zhang M; O'Keefe D; Craig J; Samley K; Bunreth V; Jolivet P; Balkan S; Marquardt T; Dousset JP; Le Paih M
Lancet Gastroenterol Hepatol; 2021 May; 6(5):371-380. PubMed ID: 33743883
[TBL] [Abstract][Full Text] [Related]
3. Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial.
Radley A; de Bruin M; Inglis SK; Donnan PT; Hapca A; Barclay ST; Fraser A; Dillon JF
Lancet Gastroenterol Hepatol; 2020 Sep; 5(9):809-818. PubMed ID: 32526210
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System.
Ioannou GN; Beste LA; Chang MF; Green PK; Lowy E; Tsui JI; Su F; Berry K
Gastroenterology; 2016 Sep; 151(3):457-471.e5. PubMed ID: 27267053
[TBL] [Abstract][Full Text] [Related]
5. Outcomes using direct-acting antiviral hepatitis-C treatment in older versus younger Veterans.
Blanquicett CJ; Raavi T; Mirk A; Johnson TM; Jaglal M; Cartwright EJ
J Am Geriatr Soc; 2021 Dec; 69(12):3602-3607. PubMed ID: 34499744
[TBL] [Abstract][Full Text] [Related]
6. Alcohol use and hepatitis C virus treatment outcomes among patients receiving direct antiviral agents.
Tsui JI; Williams EC; Green PK; Berry K; Su F; Ioannou GN
Drug Alcohol Depend; 2016 Dec; 169():101-109. PubMed ID: 27810652
[TBL] [Abstract][Full Text] [Related]
7. Curing Hepatitis C Virus Infection: Best Practices From the U.S. Department of Veterans Affairs.
Belperio PS; Chartier M; Ross DB; Alaigh P; Shulkin D
Ann Intern Med; 2017 Oct; 167(7):499-504. PubMed ID: 28973196
[TBL] [Abstract][Full Text] [Related]
8. Real-world effectiveness of daclatasvir plus sofosbuvir and velpatasvir/sofosbuvir in hepatitis C genotype 2 and 3.
Belperio PS; Shahoumian TA; Loomis TP; Mole LA; Backus LI
J Hepatol; 2019 Jan; 70(1):15-23. PubMed ID: 30266283
[TBL] [Abstract][Full Text] [Related]
9. Comparative treatment effectiveness of direct acting antiviral regimens for hepatitis C: Data from the Veterans administration.
Fox DS; McGinnis JJ; Tonnu-Mihara IQ; McCombs JS
J Gastroenterol Hepatol; 2017 Jun; 32(6):1136-1142. PubMed ID: 27869323
[TBL] [Abstract][Full Text] [Related]
10. Treatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir-based regimens: results from ERCHIVES.
Butt AA; Yan P; Shaikh OS; Chung RT; Sherman KE;
Liver Int; 2016 Sep; 36(9):1275-83. PubMed ID: 26928927
[TBL] [Abstract][Full Text] [Related]
11. Success of the US Veterans Health Administration's Hepatitis C Virus Care Continuum in the Direct-acting Antiviral Era.
Varley CD; Lowy E; Cartwright EJ; Morgan TR; Ross DB; Rozenberg-Ben-Dror K; Beste LA; Maier MM
Clin Infect Dis; 2024 Jun; 78(6):1571-1579. PubMed ID: 38279939
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C Cure Is Associated with Decreased Healthcare Costs in Cirrhotics in Retrospective Veterans Affairs Cohort.
Maier MM; Zhou XH; Chapko M; Leipertz SL; Wang X; Beste LA
Dig Dis Sci; 2018 Jun; 63(6):1454-1462. PubMed ID: 29453610
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration.
Chan K; Lai MN; Groessl EJ; Hanchate AD; Wong JB; Clark JA; Asch SM; Gifford AL; Ho SB
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1503-10. PubMed ID: 23707354
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C Care in the Department of Veterans Affairs: Building a Foundation for Success.
Belperio PS; Chartier M; Gonzalez RI; Park AM; Ross DB; Morgan TR; Backus LI
Infect Dis Clin North Am; 2018 Jun; 32(2):281-292. PubMed ID: 29778256
[TBL] [Abstract][Full Text] [Related]
15. Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label study.
Lawitz E; Landis CS; Flamm SL; Bonacini M; Ortiz-Lasanta G; Huang J; Zhang J; Kirby BJ; De-Oertel S; Hyland RH; Osinusi AO; Brainard DM; Robson R; Maliakkal BJ; Gordon SC; Gane EJ
Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):918-926. PubMed ID: 32531259
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of All-Oral Antiviral Regimens in 996 Human Immunodeficiency Virus/Hepatitis C Virus Genotype 1-Coinfected Patients Treated in Routine Practice.
Bhattacharya D; Belperio PS; Shahoumian TA; Loomis TP; Goetz MB; Mole LA; Backus LI
Clin Infect Dis; 2017 Jun; 64(12):1711-1720. PubMed ID: 28199525
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Sofosbuvir Plus Ribavirin in Veterans With Hepatitis C Virus Genotype 2 Infection, Compensated Cirrhosis, and Multiple Comorbidities.
Ho SB; Monto A; Peyton A; Kaplan DE; Byrne S; Moon S; Copans A; Rossaro L; Roy A; Le H; Dvory-Sobol H; Zhu Y; Brainard DM; Guyer W; Shaikh O; Fuchs M; Morgan TR;
Clin Gastroenterol Hepatol; 2017 Feb; 15(2):282-288. PubMed ID: 27237429
[TBL] [Abstract][Full Text] [Related]
18. Understanding associations between serious mental illness and hepatitis C virus among veterans: a national multivariate analysis.
Himelhoch S; McCarthy JF; Ganoczy D; Medoff D; Kilbourne A; Goldberg R; Dixon L; Blow FC
Psychosomatics; 2009; 50(1):30-7. PubMed ID: 19213970
[TBL] [Abstract][Full Text] [Related]
19. The association between implementation strategy use and the uptake of hepatitis C treatment in a national sample.
Rogal SS; Yakovchenko V; Waltz TJ; Powell BJ; Kirchner JE; Proctor EK; Gonzalez R; Park A; Ross D; Morgan TR; Chartier M; Chinman MJ
Implement Sci; 2017 May; 12(1):60. PubMed ID: 28494811
[TBL] [Abstract][Full Text] [Related]
20. Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection.
Grant JL; Hawkins C; Brooks H; Palella FJ; Koppe SW; Abecassis MM; Stosor V
AIDS; 2016 Jan; 30(1):93-8. PubMed ID: 26731756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
